Premature ejaculation: definition and drug treatment
- PMID: 17352514
- DOI: 10.2165/00003495-200767040-00005
Premature ejaculation: definition and drug treatment
Abstract
Premature ejaculation (PE) is a frequent male sexual complaint that is mediated mainly by disturbances of serotonergic neurotransmission and certain serotonin (5-HT) receptors and, to a lesser extent, oxytocinergic neurotransmission in the CNS. The current Diagnostic Manual of Mental Disorders (fourth edition, revised text) [DSM-IV-TR] definition of PE has a low positive predictive value and is inadequate for clinical, epidemiological and drug treatment research. Categorisation of PE into four well defined syndromes has recently been proposed for the pending DSM (fifth edition) definition of PE. Over the last decade, an increasing number of studies of drug treatment of PE have been published. A meta-analysis of those studies, conducted in accordance with current standards of evidence-based medicine, demonstrated similar efficacies for daily treatment with the serotonergic antidepressants paroxetine hemihydrate, clomipramine, sertraline and fluoxetine, with paroxetine (hydrochloride) hemihydrate exerting the strongest effect on ejaculation. On the basis of fundamental insights into serotonergic neurotransmission, it has been suggested that on-demand selective serotonin reuptake inhibitor (SSRI) treatment will not lead to similarly impressive delays in ejaculation as has been observed with daily SSRI treatment. Indeed, some on-demand studies with SSRIs and studies with the new SSRI dapoxetine have shown a weak ejaculation-delaying effect after 1-2 hours of drug intake. Apart from daily treatment with SSRIs, PE can be delayed by on-demand use of topical anaesthetics and tramadol. Treatment with phosphodiesterase type 5 inhibitors should not be prescribed to men with PE with normal erectile function, but may be used if PE is accompanied by erectile difficulties. There is no scientific support for treatment of PE with intracavernous injection of vasoactive drugs. Animal studies have shown that strong immediate ejaculation delay may be induced by administration of a combination of an SSRI with a serotonin 5-HT(1A) receptor antagonist. The combination of an SSRI and any other compound that immediately and potently raises serotonin neurotransmission and/or use of oxytocin receptor antagonists may form the basis for the development of new on-demand and/or daily drugs for the treatment of PE.
Comment in
-
Premature ejaculation: definition and drug treatment.Drugs. 2007;67(11):1629-30; author reply 1630-2. doi: 10.2165/00003495-200767110-00006. Drugs. 2007. PMID: 17661530 No abstract available.
Similar articles
-
Premature ejaculation: state of the art.Urol Clin North Am. 2007 Nov;34(4):591-9, vii-viii. doi: 10.1016/j.ucl.2007.08.011. Urol Clin North Am. 2007. PMID: 17983899 Review.
-
The pharmacological treatment of premature ejaculation.BJU Int. 2008 Sep;102(6):668-75. doi: 10.1111/j.1464-410X.2008.07719.x. Epub 2008 May 15. BJU Int. 2008. PMID: 18485043 Review.
-
Emerging drugs for premature ejaculation.Expert Opin Emerg Drugs. 2006 Mar;11(1):99-109. doi: 10.1517/14728214.11.1.99. Expert Opin Emerg Drugs. 2006. PMID: 16503829 Review.
-
Lifelong premature ejaculation: definition, serotonergic neurotransmission and drug treatment.World J Urol. 2005 Jun;23(2):102-8. doi: 10.1007/s00345-004-0491-z. Epub 2005 Jun 2. World J Urol. 2005. PMID: 15931533 Review.
-
Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation.J Sex Med. 2011 Oct;8(10):2707-25. doi: 10.1111/j.1743-6109.2011.02386.x. Epub 2011 Jul 19. J Sex Med. 2011. PMID: 21771283 Review.
Cited by
-
Current and emerging treatment options for premature ejaculation.Nat Rev Urol. 2022 Nov;19(11):659-680. doi: 10.1038/s41585-022-00639-5. Epub 2022 Aug 25. Nat Rev Urol. 2022. PMID: 36008555 Review.
-
Neurons for Ejaculation and Factors Affecting Ejaculation.Biology (Basel). 2022 Apr 29;11(5):686. doi: 10.3390/biology11050686. Biology (Basel). 2022. PMID: 35625414 Free PMC article. Review.
-
Ejaculatory and Orgasmic Dysfunction Following Prostate Cancer Therapy: Clinical Management.Med Sci (Basel). 2019 Dec 10;7(12):109. doi: 10.3390/medsci7120109. Med Sci (Basel). 2019. PMID: 31835522 Free PMC article. Review.
-
Effectiveness comparisons of Chinese patent medicine on treating premature ejaculation: A systematic review and meta-analysis.Medicine (Baltimore). 2019 Nov;98(44):e17729. doi: 10.1097/MD.0000000000017729. Medicine (Baltimore). 2019. PMID: 31689816 Free PMC article.
-
Progresses in pharmaceutical and surgical management of premature ejaculation.Chin Med J (Engl). 2019 Oct 5;132(19):2362-2372. doi: 10.1097/CM9.0000000000000433. Chin Med J (Engl). 2019. PMID: 31567373 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical